1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARBUTUS BIOPHARMA CORP
Arbutus Biopharma Corp XNAS: ABUS
4.93 0.22 (4.67%)
1.8M
XNAS Volume

XNAS 15 Dec, 2025 3:42 PM (EST)

Watchlist

Portfolio

Alert

Arbutus Biopharma Corp - ABUS - stock price prediction, stock price target, analyst ratings from 3 analysts

Arbutus Biopharma Corp has a share price target of US$ 6, revenue growth forecast of 126.8%, and profit growth estimate of 47.8% for FY25, based on top 3 analyst calls.